Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
RAMAT GAN, Israel , Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted...
Home Ultrasound Developer Pulsenmore Establishes European Operations and Appoints General Manager
/PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a global leader in self-scan ultrasound devices for remote clinical diagnosis, has appointed Mr. Johannes Scheibl...
GE Healthcare Enters Homecare Segment With Strategic Investment in Pulsenmore, Aims to Increase Peace of Mind for Expectant Mothers and Reduce In-Person Visits
GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health. This investment is aimed at...